CLINICAL_TRIALS
trial_result
· 2018-05-25
Clinical Trial Update: Prolonged Exposure and Oxytocin [Phase 2]
Summary
A Phase 2 trial update examining prolonged exposure therapy with oxytocin for post-traumatic stress disorder, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of South Carolina | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2018-05-25